--- title: "Amarin | 8-K: FY2025 Q4 Revenue Misses Estimate at USD 49.22 M" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/276883788.md" datetime: "2026-02-25T12:07:25.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/276883788.md) - [en](https://longbridge.com/en/news/276883788.md) - [zh-HK](https://longbridge.com/zh-HK/news/276883788.md) --- > 支持的语言: [English](https://longbridge.com/en/news/276883788.md) | [繁體中文](https://longbridge.com/zh-HK/news/276883788.md) # Amarin | 8-K: FY2025 Q4 Revenue Misses Estimate at USD 49.22 M Revenue: As of FY2025 Q4, the actual value is USD 49.22 M, missing the estimate of USD 50.62 M. EPS: As of FY2025 Q4, the actual value is USD 0. EBIT: As of FY2025 Q4, the actual value is USD -8.894 M. ### Financial Highlights - Fourth Quarter 2025 (Q4 2025) vs. Fourth Quarter 2024 (Q4 2024) #### Revenue - **Total Net Revenue**: Decreased to $49.2 million in Q4 2025 from $62.3 million in Q4 2024, representing a 21% decline . - **U.S. Product Revenue, net**: $41.1 million in Q4 2025 vs. $44.2 million in Q4 2024, a -7% change . - **Europe Product Revenue, net**: $2.3 million in Q4 2025 vs. $4.0 million in Q4 2024, a -42% change . - **Rest-of-World (ROW) Product Revenue, net**: $3.1 million in Q4 2025 vs. $11.9 million in Q4 2024, a -74% change . - **Total Product Revenue, net**: $46.5 million in Q4 2025 vs. $60.1 million in Q4 2024, a -23% change . - **Licensing & Royalties**: Increased to $2.7 million in Q4 2025 from $2.2 million in Q4 2024, a 20% increase . #### Operational Metrics - **Operating Expenses**: Decreased to $29.5 million in Q4 2025 from $43.0 million in Q4 2024, a -31% change . Excluding a $4.1 million restructuring charge, Q4 2025 operating expenses were $25.4 million, a 41% decline . - **Cost of Goods Sold (COGS)**: Decreased to $26.1 million in Q4 2025 from $71.9 million in Q4 2024, a -64% change . Q4 2024 COGS included a one-time inventory restructuring charge of $36.5 million . Excluding one-time charges, Q4 2025 COGS decreased $2.8 million, or 10% . - **Selling, General & Administrative (SG&A)**: Decreased to $20.1 million in Q4 2025 from $37.0 million in Q4 2024, a -46% change . - **Research & Development (R&D)**: $5.4 million in Q4 2025 vs. $6.0 million in Q4 2024, a -10% change . - **Restructuring**: $4.1 million in Q4 2025 vs. $0 in Q4 2024 . - **Operating Loss**: Narrowed significantly to -$6.3 million in Q4 2025 from -$52.5 million in Q4 2024, an 88% improvement . - **Operating Margin %**: Improved to -13% in Q4 2025 from -84% in Q4 2024 . - **Net Loss**: Improved to -$1.2 million in Q4 2025 from -$48.6 million in Q4 2024, a 97% improvement . - **Net Margin**: Improved to -2% in Q4 2025 from -78% in Q4 2024 . ### Financial Highlights - Full Year 2025 (FY 2025) vs. Full Year 2024 (FY 2024) #### Revenue - **Total Revenue, net**: $213,646 thousand in FY 2025 vs. $228,614 thousand in FY 2024 . - **Product revenue, net**: $182,753 thousand in FY 2025 vs. $204,590 thousand in FY 2024 . - **Licensing and royalty revenue**: $30,893 thousand in FY 2025 vs. $24,024 thousand in FY 2024 . #### Operational Metrics - **Cost of goods sold**: $92,778 thousand in FY 2025 vs. $110,758 thousand in FY 2024 . - **Cost of goods sold - restructuring inventory**: $0 in FY 2025 vs. $36,474 thousand in FY 2024 . - **Gross margin**: $120,868 thousand in FY 2025 vs. $81,382 thousand in FY 2024 . - **Total operating expenses**: $171,038 thousand in FY 2025 vs. $173,179 thousand in FY 2024 . - **Selling, general and administrative**: $115,003 thousand in FY 2025 vs. $152,310 thousand in FY 2024 . - **Research and development**: $19,806 thousand in FY 2025 vs. $20,869 thousand in FY 2024 . - **Restructuring**: $36,229 thousand in FY 2025 vs. $0 in FY 2024 . - **Operating loss**: -$50,170 thousand in FY 2025 vs. -$91,797 thousand in FY 2024 . - **Net loss**: -$38,798 thousand in FY 2025 vs. -$82,183 thousand in FY 2024 . #### Cash and Debt - **Cash and Investments**: Amarin Corporation plc (阿玛琳) reported $302.6 million in aggregate cash and investments as of December 31, 2025, an increase of $8.4 million from $294.2 million as of December 31, 2024, and a sequential increase of $16.0 million from $286.6 million as of September 30, 2025 . - **Debt**: The company remained debt-free as of December 31, 2025 . #### Restructuring and Cost Savings - Amarin Corporation plc (阿玛琳) realized $31 million of the expected $70 million in cost savings from its restructuring initiatives . - The company incurred nearly all of the $37 - $40 million in restructuring costs, with $36.2 million incurred in full year 2025 and remaining charges expected in early 2026 . ### Outlook / Guidance - Amarin Corporation plc (阿玛琳) expects to generate positive cash flow for the full year ahead (2026) . The company is well-positioned to deliver on its operational and strategic priorities in 2026 and continues to examine strategic actions to maximize future shareholder value and options regarding management of capital . ### 相关股票 - [Amarin (AMRN.US)](https://longbridge.com/zh-CN/quote/AMRN.US.md) ## 相关资讯与研究 - [Amarin’s European Outlook Hinges on Recordati’s VAZKEPA Execution, Raising Commercial and IP Risk](https://longbridge.com/zh-CN/news/277739630.md) - [US Supreme Court to hear 'skinny label' patent fight involving Amarin](https://longbridge.com/zh-CN/news/272872194.md) - [KDDI Revises First-Half FY2025 IFRS Results but Confirms Earnings Growth](https://longbridge.com/zh-CN/news/281160478.md) - [Key facts: Bunge Increases Securitization to $2.0B; 8-K on Obligation](https://longbridge.com/zh-CN/news/281659964.md) - [Wealth First Promoters Confirm 74% Stake With No Encumbrance in FY26](https://longbridge.com/zh-CN/news/281530653.md)